Philippe Généreux, MD, is a Cofounder and Chief Medical Officer of Spiralis Medical and a member of its Board of Directors.

Philippe currently serves as Director of the Structural Heart Program and Interventional Cardiology at Morristown Medical Center (2016–present). He previously served as Director of the Transcatheter Valve Program at Hôpital du Sacré-Coeur de Montréal, and as Director of the Angiographic Core Laboratory at the Cardiovascular Research Foundation and Columbia University Medical Center.

Philippe has authored over 400 peer-reviewed publications and holds an h-index of 99 on Google Scholar. He has been named a Highly Cited Researcher by the Clarivate Web of Science Group for five consecutive years (2019–2024). He serves as Global Principal Investigator on multiple pivotal device trials, including EARLY TAVR and PROGRESS (Edwards Lifesciences), ECLIPSE (Abbott) and has performed numerous first-in-human procedures worldwide. 

Philippe earned his medical degree from Université de Montréal (1996) and completed his certifications in Internal Medicine and Cardiology at Université de Sherbrooke, followed by an Interventional Cardiology Fellowship at Hôpital du Sacré-Coeur de Montréal and a further fellowship at Columbia University Medical Center and the Cardiovascular Research Foundation in New York.